Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES)

Gynecologic Oncology

Volumn 76, Issue 2, 2000, Pages 147-156

  Herbst, Arthur L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN;

ADOLESCENT; ADULT; CANCER GROWTH; CANCER RECURRENCE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DRUG STRUCTURE; FEMALE; GENITAL TRACT CANCER; HISTOGENESIS; HORMONE ACTION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033969978     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5471     Document Type: Review

References (35)

1. Smith O W, Smith G BS, Hurwitz D. Increased excretion of pregnanediol in pregnancy from diethylstilbestrol with special reference to the prevention of late pregnancy accidents. Am J Obstet Gynecol. 51:1946;411-415.
2. Dieckmann W. Does the administration of diethylstilbestrol during pregnancy have therapeutic value. Am J Obstet Gynecol. 66:1953;1062-1081.
3. Herbst A L, Ulfelder H, Poskanzer D C. Adenocarcinoma of the vagina: an association of maternal stilbestrol therapy with tumor appearing in young women. N Engl J Med. 284:1971;878-881.
4. FDA Drug Bulletin: Diethylstilbestrol contraindicated in pregnancy, U.S. Department of Health, Education, and Welfare, 1971.
5. Herbst A L, Kurman R J, Scully R E, Poskanzer D C. Clear-cell adenocarcinoma of the genital tract in young females: registry report. N Engl J Med. 287:1972;1259.
6. Melnick S, Cole P, Anderson D, Herbst A L. Rates and risks of diethylstilbestrol related to clear cell adenocarcinoma of the vagina and cervix. N Engl J Med. 316:1987;514-516.
7. Hanselaar A, van Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bernheim J. Clear cell adenocarcinoma of the vagina and cervix. An update of Central Netherlands Registry showing twin age incidence peaks. Cancer. 79:1997;2229-2236.
8. Herbst A L, Anderson S, Hubby M M, Haenszel W M, Kaufman R H, Noller K L. Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 154:1986;814-822.
9. Herbst A L, Cole P, Norusis M J, Welch W R, Scully R E. Epidemiologic aspects and factors related to survival in 384 registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 135:1979;876-883.
10. Scully R E, Robboy S J, Welch W R. Pathology and Pathogenesis of Diethylstilbestrol-Related Disorders of the Female Genital Tract. Herbst A L. Intrauterine Exposure to Diethylstilbestrol in the Human. 1978;American College of Obstetricians and Gynecologists, Washington.
11. Senekjian E K, Frey K W, Anderson D, Herbst A L. Local therapy in Stage I clear cell adenocarcinoma of the vagina. Cancer. 60:1987;1319-1324.
12. Wharton J T, Fletcher G H, Delclos L. Invasive Tumors of the Vagina: Clinical Features and Management. Coppleson M. Gynecologic Oncology: Fundamental Principles and Clinical Practice. 1981;345-359 Churchill Livingstone, New York.
13. Mishell D R, Stenchever M A, Droegemueller W, Herbst A L. Comprehensive Gynecology. 1997;Missouri Mosby Yearbook, St. Louis.
14. Greenberg E R, Barnes A B, Resseguie L, Barrett J A, Burnside S, Lanza L L, Neff R K, Stevens M, Young R H, Colton T. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med. 311:1984;1393.
15. Colton T, Greenberg E R, Noller K, Resseguie L, Van Bennekom C, Heeren T, Zhang Y. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. J Am Med Assoc. 269:1993;2096.
16. Calle E E, Mervis C A, Thun M J, Rodriguez C, Wingo P A, Heath C W. DES and risk of fatal breast cancer in a prospective cohort of U.S. women. Am J Epidemiol. 144:1996;64.
17. Wilcox A J, Baird D D, Weinberg C R, Hornsby P P, Herbst A L. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med. 332:1995;1411-1416.
18. Forsberg J G, Kalland T. Embryology of the Genital Tract in Humans and Rodents. Herbst A L, Bern H A. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. 1981;Thieme Stratton, New York.
19. Kaufman R H, Adam E, Binder G L, Gerthoffer E. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol. 137:1980;299.
20. Kaufman R H, Noller K L, Adam E, Irwin J, Gray M, Jeffries J A, Hilton J. Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny. Am J Obstet Gynecol. 148:1984;973.
21. Cunha G, Fujii H. Stromal-Parenchymal Interactions in Normal and Abnormal Development of the Genital Tract. Herbst A L, Herbs H A. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. 1981;Thieme Stratton, New York.
22. Scully R E, Welch W R. Pathology of the Female Genital Tract after Prenatal Exposure to Diethylstilbestrol. Herbst A L, Bern H A. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. 1981;Thieme Stratton, New York.
23. Kurman R J, Scully R E. The incidence and histogenesis of vaginal adenosis: an autopsy study. Hum Pathol. 5:1974;265.
24. Dickersin G R, Welch W R, Erlandson R, Robboy S J. Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. Cancer. 45:1980;1615.
25. Navani S S, Alverado-Cabrero I, Young R H, Scully R E. Endometriod carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases. Gynecol Oncol. 63:1996;371.
26. DeMars L R, Van Le L, Huang I, Fowler W C. Case report: primary non-clear cell adenocarcinomas of the vagina in older DES-exposed women. Gynecol Oncol. 58:1995;389.
27. Waggoner S E, Mittendorf R, Biney N, Anderson D, Herbst A L. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear cell adenocarcinoma. Gynecol Oncol. 55:1994;238.
28. Brinton L A, Hoover R N. The Endometrial Cancer Collaborative Group: Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstet Gynecol. 81:1993;265.
29. Weiss N S, Szekely D R, English D R, Scweid A I. Endometrial cancer in relation to patterns of menopausal estrogen use. J Am Med Assoc. 242:1979;261.
30. Mack T M, Pike M C, Henderson B E, Pfeffer R I, Gerkins V R, Arthur M, Brown S E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 294:1976;1262.
31. Smith D C, Prentice R, Thompson D J, Hermann W L. Association of exogenous estrogen and endometrial cancer. N Engl J Med. 293:1975;1164.
32. Hulka B S, Kaufman D G, Fowler W C, Grisom R C, Greenberg B G. Predominance of early endometrial cancers after long-term estrogen use. J Am Med Assoc. 244:1980;2419.
33. Collins J, Donner A, Allen L H, Adams O. Oestrogen use and survival in endometrial cancer. Lancet. November 1, 1980;961-964.
34. Lancet. 347:1996;1713.
35. Lancet. 350:1997;1047.